Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial

AIM: To examine whether the velocity of saccadic eye movements in internuclear ophthalmoparesis (INO) improves with fampridine treatment in patients with multiple sclerosis (MS). METHODS: Randomized, double‐blind, placebo‐controlled, cross‐over trial with fampridine in patients with MS and INO. Hori...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanhai, Kawita M. S., Nij Bijvank, Jenny A., Wagenaar, Yorick L., Klaassen, Erica S., Lim, KyoungSoo, Bergheanu, Sandrin C., Petzold, Axel, Verma, Ajay, Hesterman, Jacob, Wattjes, Mike P., Uitdehaag, Bernard M. J., van Rijn, Laurentius J., Groeneveld, Geert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515699/
https://www.ncbi.nlm.nih.gov/pubmed/30756475
http://dx.doi.org/10.1111/cns.13096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515699/
https://www.ncbi.nlm.nih.gov/pubmed/30756475
http://dx.doi.org/10.1111/cns.13096

Ejemplares similares